Email this article The results of real-world practice with glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection genotypes 1 and 3 in adolescents aged 12 to 17 years in the Moscow region - PDF (Russian)
Copyright (c) 2023 Meskina E.R., Tselipanova E.E., Galkina L.A.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.